OKYO Pharma Announces Chairman and Founder Acquires Shares

Summary by AI BETAClose X

OKYO Pharma Limited announced that Panetta Partners Limited, an entity with a beneficial interest held by Executive Chairman Gabriele Cerrone, acquired 24,551 ordinary shares on NASDAQ, increasing his total holding to 10,516,297 shares. This acquisition by a key insider may signal confidence in the company's development of urcosimod, a novel drug candidate for neuropathic corneal pain and dry eye disease, which has completed Phase 2 trials for both indications.

Disclaimer*

UK 100

Latest directors dealings